| Bioactivity | c-Met-IN-9, a 4-phenoxypyridine derivative, is a c-Met kinas inhibitor with an IC50 of 12 nM. c-Met-IN-9 induces cells apoptosis, and has antitumor activities[1]. |
| Invitro | c-Met-IN-9 (Compound T14) shows remarkable antiproliferative activities against MKN-45, A549 and H460 cell lines with IC50 values of 0.64 μM, 1.92 μM and 2.68 μM, respectively[1]. c-Met-IN-9 could inhibit cells colony formation, induce cells apoptosis, and inhibit cells motility[1]. |
| Name | c-Met-IN-9 |
| CAS | 2760326-29-0 |
| Formula | C25H19F2N5O3 |
| Molar Mass | 475.45 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
c-Met-IN-9
CAS: 2760326-29-0 F: C25H19F2N5O3 W: 475.45
c-Met-IN-9, a 4-phenoxypyridine derivative, is a c-Met kinas inhibitor with an IC50 of 12 nM. c-Met-IN-9 induces cells a
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.